The regenerative medicine arm of Relievus, a multi-site pain management group in New Jersey and Pennsylvania, with a Havertown office among its locations.
This listing covers the regenerative medicine service of Relievus, a pain management group practice operating across southern New Jersey and south-eastern Pennsylvania. The stemcellprp.com site is a dedicated microsite for the group's injection-based regenerative offering rather than a separate clinic, and it points readers back to the wider Relievus practice for scheduling.
The site lists seventeen offices. Three are in Pennsylvania: Havertown at 700 East Township Line Road, a Philadelphia office at 9815 Roosevelt Boulevard, and Wyomissing at 2760 Century Boulevard. The remaining fourteen are in New Jersey, spread between Atco, Burlington, Cherry Hill, Hamilton, Hammonton, Jackson, Linwood, Lumberton, Neptune, North Brunswick, Sewell, Toms River, Vineland and Woodbury Heights. A single central telephone number, 888-985-2727, covers all sites.
According to the site, the service offers stem cell therapy and platelet rich plasma (PRP, prepared from the patient's own blood) as non-surgical options for back and neck pain and for joint injuries. Notably, the site includes its own plain disclaimer that regenerative medicine including PRP and stem cell injection therapy is not approved by the United States Food and Drug Administration. A prospective patient should read that disclaimer carefully and ask what it means for their particular treatment.
The site does not state where its stem cells come from. There is no statement in the material reviewed as to whether cells are autologous (from the patient's own body, such as bone marrow or fat) or allogeneic (from a donor, such as umbilical cord tissue), and no laboratory or processing detail. It also names no individual clinicians. Both gaps are significant: anyone considering treatment here would need to ask in writing what cell product is used, where it is sourced and processed, and which named doctor would carry out the procedure at the Havertown office.
The site describes its regenerative offering in broad terms rather than listing named diagnoses.
The site promotes stem cell injection therapy alongside platelet rich plasma but does not state what kind of stem cells are used or where they come from.
The site does not name any individual clinician in the material reviewed; a prospective patient would need to ask which doctor would perform the procedure.
The Havertown office is one of seventeen listed locations, at 700 East Township Line Road, Havertown, Pennsylvania. The site gives addresses only and does not describe the premises at any site, nor state whether procedures are carried out in an office treatment room or a procedure suite, whether imaging guidance is used, or whether any cell processing happens on site. No accreditation is claimed.
The site does not publish any prices, and says nothing about whether regenerative procedures are covered by insurance. Given the site's own statement that these therapies are not approved by the United States Food and Drug Administration, a prospective patient should assume self-payment is likely and ask for a written quote before booking.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.